Ipratropium is a bronchodilator medication that dilates the airways of the lungs. Ipratropium has been approved by the US Food and Drug Administration (FDA) for treating bronchospasms associated with chronic obstructive pulmonary disease (COPD), including emphysema and chronic bronchitis. Maintenance therapy with ipratropium has established benefits in the treatment of COPD. Understanding the broad-spectrum therapeutic potential of ipratropium, including its FDA-approved indications for bronchospasms associated with COPD and off-label uses for asthma exacerbations and rhinorrhea, is crucial.Incorporating ipratropium alongside short-acting beta-agonists in managing severe asthma exacerbations and utilizing its nasal spray formulation for symptomatic relief of rhinorrhea associated with the common cold or allergic rhinitis highlights its versatility in clinical practice. The diverse formulations, such as nasal spray, metered-dose inhaler, and nebulized solution, allow customized treatment approaches across different patient populations. This activity reviews the indications, mechanism of action, administration, drug interactions, and adverse reactions of ipratropium, highlighting the importance of interprofessional healthcare teams involving clinicians, pharmacists, and pulmonologists to ensure effective ipratropium therapy. This activity also fosters collaborative practice among healthcare professionals, enabling them to enhance their understanding and utilization of ipratropium through shared decision-making, thereby contributing toward improved patient outcomes in respiratory care.
- Provider:StatPearls, LLC
- Activity Link: https://www.statpearls.com/ArticleLibrary/viewarticle/23760
- Start Date: 2023-09-01 05:00:00
- End Date: 2023-09-01 05:00:00
- Credit Details: IPCE Credits: 1.0 hours
AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - MOC Credit Details: ABS - 1.0 Point; Credit Type(s): Accredited CME (ABS)
ABOS - 1.0 Point; Credit Type(s): Accredited CME (ABOS)
ABPATH - 1.0 Point; Credit Type(s): Lifelong Learning (ABPATH)
ABA - 1.0 Point; Credit Type(s): Lifelong Learning (ABA)
ABTS - 1.0 Point; Credit Type(s): Accredited CME (ABTS)
ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
ABS - 1.0 Point; Credit Type(s): Self-Assessment (ABS)
ABP - 1.0 Point; Credit Type(s): Lifelong Learning and Self-Assessment (ABP)
ABTS - 1.0 Point; Credit Type(s): Self-Assessment (ABTS) - Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Variable
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Adolescent Medicine, Ambulatory/Outpatient, Chemical Pathology, Critical Care, Critical Care Medicine, Forensic Pathology, General Operative Anesthesia, Geriatric Medicine, Hospital Medicine, Internal Medicine, Neurocritical Care, Orthopaedic Sports Medicine, Pediatric Critical Care Medicine, Pediatric Emergency Medicine, Pediatric Pulmonology, Pulmonary Disease, Surgical Critical Care, Thoracic Anesthesia, Trauma